ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2017, Vol. 26 ›› Issue (2): 119-124.DOI: 10.3969/cndt.j.issn.1006-298X.2017.02.004

• 论文 • 上一篇    下一篇

微型多血管炎伴肺部损害患者的疗效反应及远期预后

  

  • 出版日期:2017-04-27 发布日期:2017-04-28

Manifestation and longterm prognosis in microscopic polyangiitis patients with pulmonary involvement

  • Online:2017-04-27 Published:2017-04-28

摘要:

目的:分析伴或不伴肺损害的微型多血管炎(MPA)患者的临床特征及远期预后差异。
方法:1995年12月至2014年12月间南京军区南京总医院确诊为MPA的患者196例(男80例,女116例,平均年龄52岁),中位病程20个月(10~60个月),基线中位血清肌酐3448 μmol/L(1768~5569 μmol/L),其中70例(357%)起病需肾脏替代治疗。回顾性分析肺损害对MPA疗效、人肾存活率及远期预后的影响。利用KaplanMeier法计算患者的人肾存活率,并利用COX回归模型分析临床及病理指标与远期人存活相关性。
结果:196例患者平均随访389±420个月,期间20例(102%)死亡,81例(413%)进入终末期肾病(ESRD)。111例(566%)患者伴有肺损害,最常见临床症状为咯血、咳嗽咳痰,胸部CT或X线检查以斑片影、条索影及胸膜增厚多见。肺损害组年龄、男性和吸烟比例、伯明翰血管炎活动性评分、血清肌酐及MPOANCA滴度均显著高于无肺损害组(P<005)。1年内肺损害组和无肺损害组完全缓解率分别为135%、212%(P=0155);治疗无效比例分别为423%、353%(P=0317)。肺损害组的人存活率更低(P=0013);两组肾存活率无统计学差异。多因素COX回归分析显示肺损害及起病时肾脏替代治疗为影响患者存活的独立危险因素。
结论:伴有肺损害的MPA患者年龄更大、血管炎更活动,肺损害是影响MPA患者存活的独立危险因素。

关键词: 肺损害, 微型多血管炎, 人存活率, 危险因素

Abstract:

Objective:To analyze the clinical characteristics and longterm prognosis of patients with microscopic polyangiitis(MPA) with and without pulmonary involvement.
Methodology:196 MPA patients with renal involvement were enrolled in the study. The median serum creatinine (SCr) was 3448 (1768~5569) μmol/L, 70(357%) of them needed renal replacement therapy at diagnosis. The prognosis and risk factor of MPA with pulmonary involvement were retrospectively studied. Survival Curve was estimated by KaplanMeier methods, and multivariate Cox regression analysis is applied to probe into the correlation between clinical features as well as pathological parameters and longterm human survival outcome.
Results:With a mean followup time of 389±420 months, 20 patients died, 81(413%) developed end stage renal disease(ESRD). The pulmonary involvements were observed in 111 MPA patients, their main clinical symptoms included hemoptysis and  cough; CT or Xray manifestations included patchy, funicular shadow and pleural thickening. The age, proportion of male patients and smokers, BVAS score, serum creatinine and MPOANCA level in pulmonary involvement group were apparently higher than those of nonpulmonary involvement group (P<005). The 1year complete remission rate was 135% and 212% (P=0155) in patients with and without pulmonary involvement; while their ineffective treatment proportion was respectively 423% and 353% (P=0317). Patient survival rate in pulmonary involvement group was significantly lower (P=0013); renal survival was not differed between two groups. Cox multivariate analysis indicated that lung involvement and dialysis dependent on admission were significant negative prognostic factors for patients survival.
Conclusion:The vasculitis of older MPA patients with lung damage was more active. Lung involvement was an independent risk factor for human survival.

 

Key words: Lung damage, MPA, Patient , survival, Risk factor